CAM
ANGO icon

ClariVest Asset Management’s AngioDynamics ANGO Stock Holding History

ClariVest Asset Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-40,826
Closed -$422K – 659
2023
Q1 		$422K Buy
40,826
+26
+0.1% +$333 0.02% 398
2022
Q4 		$561K Buy
40,800
+12,000
+42% +$167K 0.03% 370
2022
Q3 		$589K Hold
28,800
– – 0.03% 341
2022
Q2 		$557K Sell
28,800
-100
-0.3% -$2.05K 0.02% 361
2022
Q1 		$622K Sell
28,900
-4,500
-13% -$102K 0.02% 348
2021
Q4 		$921K Sell
33,400
-500
-1% -$13.8K 0.03% 337
2021
Q3 		$880K Sell
33,900
-300
-0.9% -$8.02K 0.03% 337
2021
Q2 		$927K Hold
34,200
– – 0.03% 306
2021
Q1 		$800K Buy
34,200
+1,800
+6% +$36.4K 0.03% 321
2020
Q4 		$497K Sell
32,400
-400
-1% -$5.08K 0.02% 379
2020
Q3 		$395K Sell
32,800
-2,000
-6% -$19K 0.01% 381
2020
Q2 		$354K Buy
34,800
+6,358
+22% +$65.5K 0.01% 455
2020
Q1 		$297K Sell
28,442
-1,500
-5% -$18.8K 0.01% 448
2019
Q4 		$479K Sell
29,942
-100
-0.3% -$1.53K 0.01% 429
2019
Q3 		$553K Sell
30,042
-300
-1% -$5.87K 0.01% 404
2019
Q2 		$598K Sell
30,342
-400
-1% -$8.15K 0.01% 352
2019
Q1 		$703K Sell
30,742
-6,705
-18% -$146K 0.01% 434
2018
Q4 		$753K Sell
37,447
-4,813
-11% -$99.6K 0.02% 423
2018
Q3 		$919K Sell
42,260
-16,998
-29% -$378K 0.02% 436
2018
Q2 		$1.32M Buy
+59,258
New +$1.21M 0.02% 408
2015
Q2 		– Sell
-9,088
Closed -$162K – 604
2015
Q1 		$162K Hold
9,088
– – ﹤0.01% 419
2014
Q4 		$172K Sell
9,088
-12,039
-57% -$204K 0.01% 361
2014
Q3 		$290K Buy
21,127
+623
+3% +$8.89K 0.01% 325
2014
Q2 		$335K Hold
20,504
– – 0.01% 311
2014
Q1 		$323K Sell
20,504
-8,118
-28% -$132K 0.01% 315
2013
Q4 		$492K Buy
+28,622
New +$440K 0.02% 277

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClariVest Asset Management's ANGO Position: Q2 2023 in Review

ClariVest Asset Management sold out of AngioDynamics (ANGO) in Q2 2023, closing a stake of 40,826 shares — an estimated $422K sold.

ClariVest Asset Management first reported a position in ANGO in Q4 2013 and held it in 26 quarters. The position peaked at $1.32M in Q2 2018. 156 funds tracked by Wall St. Rank hold ANGO as of Q2 2023.

  • ClariVest Asset Management reported no remaining AngioDynamics position as of Q2 2023 after selling out during the quarter.
  • ClariVest Asset Management sold 40,826 AngioDynamics shares in Q2 2023, an estimated $422K.
  • ClariVest Asset Management first reported a position in AngioDynamics in Q4 2013 and held it in 26 quarters.
  • ClariVest Asset Management's AngioDynamics position peaked at $1.32M in Q2 2018.
  • 156 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2023.

Based on ClariVest Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.